The aspirin market size has grown steadily in recent years. It will grow from $2.56 billion in 2024 to $2.68 billion in 2025 at a compound annual growth rate (CAGR) of 4.7%. The growth in the historic period can be attributed to pain management and analgesic demand, cardiovascular health awareness, anti-inflammatory properties, preventive measures for stroke and heart attacks, treatment of fever and headaches, rheumatic fever and arthritis treatment.
The aspirin market size is expected to see strong growth in the next few years. It will grow to $3.38 billion in 2029 at a compound annual growth rate (CAGR) of 6%. The growth in the forecast period can be attributed to rising incidence of chronic diseases, potential benefits in neurological disorders, pharmaceutical industry innovations, increased adoption in developing regions, growing popularity of self-care practices. Major trends in the forecast period include cancer prevention research, combination therapies, personalized medicine approaches, customized dosage forms and delivery systems, telemedicine and self-care.
The rising incidence of arthritis is projected to drive the growth of the aspirin market in the coming years. Arthritis is a medical condition characterized by pain and swelling in the joints. Aspirin, a nonsteroidal anti-inflammatory drug, aids individuals with chronic pain from arthritis and other ailments by alleviating inflammation, reducing pain, and enhancing functionality. An increase in arthritis cases directly correlates with higher aspirin usage. For example, in November 2023, the Health and Safety Executive (HSE), a UK government agency, reported that the total number of workers suffering from work-related musculoskeletal disorders reached 473,000 during the 2022-2023 period, reflecting a prevalence rate of 1,400 per 100,000 workers. Additionally, there were 132,000 new cases, indicating an incidence rate of 390 per 100,000 workers. Consequently, the growing prevalence of arthritis is fueling the expansion of the aspirin market.
The significant global burden of cardiovascular diseases is expected to further propel the growth of the aspirin market in the future. Cardiovascular diseases encompass a range of disorders affecting the heart and blood vessels. Aspirin is frequently recommended as a preventive measure for cardiovascular diseases, especially for individuals at risk of heart attacks or strokes. For instance, in May 2024, the Singapore Heart Foundation (SHF), a Singapore-based non-profit organization, reported that ischemic heart diseases accounted for 5,302 deaths, reflecting a slight increase from 5,290 deaths in 2022. Therefore, the substantial burden of cardiovascular diseases worldwide is anticipated to drive the aspirin market.
Major companies in the aspirin market are increasingly adopting a strategic partnership approach to enhance technology integration and broaden their market reach. A strategic partnership generally involves a collaborative relationship between two or more organizations, where they combine their resources, expertise, and efforts to achieve shared goals. For example, in February 2023, Huma Therapeutics Limited (Huma), a digital health company based in the UK, collaborated with Bayer AG, a Germany-based life sciences firm, to launch the Bayer Aspirin Heart Risk Assessment online tool. This tool helps users identify their risk factors for developing cardiovascular disease over the next decade and enables them to share their results with their healthcare providers. Huma has created an algorithm that predicts long-term cardiovascular disease risk using data from the UK Biobank. Individuals can access the Heart Risk Assessment tool on the Bayer Aspirin website, where they will find a user-friendly questionnaire containing 15 questions. Based on their answers, the tool evaluates whether they are at higher, average, or lower risk of developing cardiovascular disease by comparing their responses to data from the research population.
In May 2024, Sun Pharmaceutical Industries Ltd., a specialty generic pharmaceutical company based in India, acquired Taro Pharmaceutical Industries Ltd. for an undisclosed amount. This acquisition is intended to enhance Sun Pharma's presence in the pharmaceutical market, particularly in segments like off-patent pharmaceuticals, prescription medications, and over-the-counter products. Taro Pharmaceutical Industries Ltd., located in Israel, is a research-focused pharmaceutical manufacturer known for producing acetylsalicylic acid capsules.
In March 2022, Advent International Corporation, a US-based investment firm, acquired the over-the-counter (OTC) and pharmaceutical businesses in Mexico and Brazil from Perrigo Company plc for an undisclosed amount. This acquisition allows Advent to expand its regional investment strategy within the healthcare sector, drawing on over twenty years of industry experience to strengthen its market position. Perrigo Company plc is an Ireland-based manufacturer of pharmaceutical products, including aspirin tablets.
Major companies operating in the aspirin market include Bayer AG, Allegiant Health, Par Pharmaceutical, Cardinal Health Inc., Nanjing pharmaceutical factory Co. Ltd., JQC (Huayin) Pharmaceutical Co. Ltd., LNK International Inc., Bal Pharma Limited, Trumac Healthcare, Perrigo Company PLC, Alta Laboratories Ltd., Zhenjiang Gaopeng Pharmaceutical Co. Ltd., J.M. Loveridge Ltd., Mayne Pharma Group Limited, St. Joseph's Aspirin, Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim International GmbH, Cadila Healthcare Ltd., Cipla Ltd., Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, Hetero Labs Ltd., Jubilant Generics Ltd., Lupin Ltd., Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Sun Pharmaceutical Industries Ltd.
Asia-Pacific was the largest region in the aspirin market in 2024. The regions covered in the aspirin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the aspirin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Aspirin, also known as acetylsalicylic acid (ASA), is a non-steroidal anti-inflammatory drug used to treat fever and minor aches. It is employed for conditions such as arthritis and to mitigate the risk of issues such as heart attacks and strokes.
There are two primary types of aspirin products such as prescription and over-the-counter (OTC). Prescription drugs can only be obtained with a certified physician's prescription. As for the route of administration, aspirin comes in oral, rectal, and parenteral forms. Various dosage forms include tablets, capsules, injections, and suppositories. Aspirin finds applications in diverse areas, including cardiovascular disease, pain relief, fever reduction, inflammation management, among others. It is utilized by a range of end-users, such as hospitals, clinics, and other healthcare facilities.
The aspirin market research report is one of a series of new reports that provides aspirin market statistics, including aspirin industry global market size, regional shares, competitors with a aspirin market share, detailed aspirin market segments, market trends and opportunities, and any further data you may need to thrive in the aspirin industry. This aspirin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The aspirin market consists of sales of capsules, chewable, and coated tablets. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The aspirin market size is expected to see strong growth in the next few years. It will grow to $3.38 billion in 2029 at a compound annual growth rate (CAGR) of 6%. The growth in the forecast period can be attributed to rising incidence of chronic diseases, potential benefits in neurological disorders, pharmaceutical industry innovations, increased adoption in developing regions, growing popularity of self-care practices. Major trends in the forecast period include cancer prevention research, combination therapies, personalized medicine approaches, customized dosage forms and delivery systems, telemedicine and self-care.
The rising incidence of arthritis is projected to drive the growth of the aspirin market in the coming years. Arthritis is a medical condition characterized by pain and swelling in the joints. Aspirin, a nonsteroidal anti-inflammatory drug, aids individuals with chronic pain from arthritis and other ailments by alleviating inflammation, reducing pain, and enhancing functionality. An increase in arthritis cases directly correlates with higher aspirin usage. For example, in November 2023, the Health and Safety Executive (HSE), a UK government agency, reported that the total number of workers suffering from work-related musculoskeletal disorders reached 473,000 during the 2022-2023 period, reflecting a prevalence rate of 1,400 per 100,000 workers. Additionally, there were 132,000 new cases, indicating an incidence rate of 390 per 100,000 workers. Consequently, the growing prevalence of arthritis is fueling the expansion of the aspirin market.
The significant global burden of cardiovascular diseases is expected to further propel the growth of the aspirin market in the future. Cardiovascular diseases encompass a range of disorders affecting the heart and blood vessels. Aspirin is frequently recommended as a preventive measure for cardiovascular diseases, especially for individuals at risk of heart attacks or strokes. For instance, in May 2024, the Singapore Heart Foundation (SHF), a Singapore-based non-profit organization, reported that ischemic heart diseases accounted for 5,302 deaths, reflecting a slight increase from 5,290 deaths in 2022. Therefore, the substantial burden of cardiovascular diseases worldwide is anticipated to drive the aspirin market.
Major companies in the aspirin market are increasingly adopting a strategic partnership approach to enhance technology integration and broaden their market reach. A strategic partnership generally involves a collaborative relationship between two or more organizations, where they combine their resources, expertise, and efforts to achieve shared goals. For example, in February 2023, Huma Therapeutics Limited (Huma), a digital health company based in the UK, collaborated with Bayer AG, a Germany-based life sciences firm, to launch the Bayer Aspirin Heart Risk Assessment online tool. This tool helps users identify their risk factors for developing cardiovascular disease over the next decade and enables them to share their results with their healthcare providers. Huma has created an algorithm that predicts long-term cardiovascular disease risk using data from the UK Biobank. Individuals can access the Heart Risk Assessment tool on the Bayer Aspirin website, where they will find a user-friendly questionnaire containing 15 questions. Based on their answers, the tool evaluates whether they are at higher, average, or lower risk of developing cardiovascular disease by comparing their responses to data from the research population.
In May 2024, Sun Pharmaceutical Industries Ltd., a specialty generic pharmaceutical company based in India, acquired Taro Pharmaceutical Industries Ltd. for an undisclosed amount. This acquisition is intended to enhance Sun Pharma's presence in the pharmaceutical market, particularly in segments like off-patent pharmaceuticals, prescription medications, and over-the-counter products. Taro Pharmaceutical Industries Ltd., located in Israel, is a research-focused pharmaceutical manufacturer known for producing acetylsalicylic acid capsules.
In March 2022, Advent International Corporation, a US-based investment firm, acquired the over-the-counter (OTC) and pharmaceutical businesses in Mexico and Brazil from Perrigo Company plc for an undisclosed amount. This acquisition allows Advent to expand its regional investment strategy within the healthcare sector, drawing on over twenty years of industry experience to strengthen its market position. Perrigo Company plc is an Ireland-based manufacturer of pharmaceutical products, including aspirin tablets.
Major companies operating in the aspirin market include Bayer AG, Allegiant Health, Par Pharmaceutical, Cardinal Health Inc., Nanjing pharmaceutical factory Co. Ltd., JQC (Huayin) Pharmaceutical Co. Ltd., LNK International Inc., Bal Pharma Limited, Trumac Healthcare, Perrigo Company PLC, Alta Laboratories Ltd., Zhenjiang Gaopeng Pharmaceutical Co. Ltd., J.M. Loveridge Ltd., Mayne Pharma Group Limited, St. Joseph's Aspirin, Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim International GmbH, Cadila Healthcare Ltd., Cipla Ltd., Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, Hetero Labs Ltd., Jubilant Generics Ltd., Lupin Ltd., Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Sun Pharmaceutical Industries Ltd.
Asia-Pacific was the largest region in the aspirin market in 2024. The regions covered in the aspirin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the aspirin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Aspirin, also known as acetylsalicylic acid (ASA), is a non-steroidal anti-inflammatory drug used to treat fever and minor aches. It is employed for conditions such as arthritis and to mitigate the risk of issues such as heart attacks and strokes.
There are two primary types of aspirin products such as prescription and over-the-counter (OTC). Prescription drugs can only be obtained with a certified physician's prescription. As for the route of administration, aspirin comes in oral, rectal, and parenteral forms. Various dosage forms include tablets, capsules, injections, and suppositories. Aspirin finds applications in diverse areas, including cardiovascular disease, pain relief, fever reduction, inflammation management, among others. It is utilized by a range of end-users, such as hospitals, clinics, and other healthcare facilities.
The aspirin market research report is one of a series of new reports that provides aspirin market statistics, including aspirin industry global market size, regional shares, competitors with a aspirin market share, detailed aspirin market segments, market trends and opportunities, and any further data you may need to thrive in the aspirin industry. This aspirin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The aspirin market consists of sales of capsules, chewable, and coated tablets. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Aspirin Market Characteristics3. Aspirin Market Trends and Strategies4. Aspirin Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market32. Global Aspirin Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Aspirin Market34. Recent Developments in the Aspirin Market
5. Global Aspirin Growth Analysis and Strategic Analysis Framework
6. Aspirin Market Segmentation
7. Aspirin Market Regional and Country Analysis
8. Asia-Pacific Aspirin Market
9. China Aspirin Market
10. India Aspirin Market
11. Japan Aspirin Market
12. Australia Aspirin Market
13. Indonesia Aspirin Market
14. South Korea Aspirin Market
15. Western Europe Aspirin Market
16. UK Aspirin Market
17. Germany Aspirin Market
18. France Aspirin Market
19. Italy Aspirin Market
20. Spain Aspirin Market
21. Eastern Europe Aspirin Market
22. Russia Aspirin Market
23. North America Aspirin Market
24. USA Aspirin Market
25. Canada Aspirin Market
26. South America Aspirin Market
27. Brazil Aspirin Market
28. Middle East Aspirin Market
29. Africa Aspirin Market
30. Aspirin Market Competitive Landscape and Company Profiles
31. Aspirin Market Other Major and Innovative Companies
35. Aspirin Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Aspirin Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on aspirin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for aspirin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The aspirin market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- the market characteristics section of the report defines and explains the market.
- the market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- the forecasts are made after considering the major factors currently impacting the market. These include:
- the forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- the regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- the competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- the trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) by Product: Prescription; OTC2) by Route of Administration: Oral; Rectal; Parenteral
3) by Dosage Form: Tablets; Capsules; Injections; Suppositories
4) by Application: Cardiovascular Disease; Pain, Fever, O Inflammation; Other Applications
5) by End User: Hospitals; Clinics; Other End Users
Subsegments:
1) by Prescription Aspirin: Low-Dose Aspirin (81 Mg); High-Dose Aspirin (325 Mg)2) by OTC (Over-the-Counter) Aspirin: Regular Strength Aspirin (325 Mg); Extra-Strength Aspirin (500 Mg); Buffered Aspirin; Aspirin Combinations
Key Companies Mentioned: Bayer AG; Allegiant Health; Par Pharmaceutical; Cardinal Health Inc.; Nanjing pharmaceutical factory Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
Some of the major companies featured in this Aspirin market report include:- Bayer AG
- Allegiant Health
- Par Pharmaceutical
- Cardinal Health Inc.
- Nanjing pharmaceutical factory Co. Ltd.
- JQC (Huayin) Pharmaceutical Co. Ltd.
- LNK International Inc.
- Bal Pharma Limited
- Trumac Healthcare
- Perrigo Company PLC
- Alta Laboratories Ltd.
- Zhenjiang Gaopeng Pharmaceutical Co. Ltd.
- J.M. Loveridge Ltd.
- Mayne Pharma Group Limited
- St. Joseph's Aspirin
- Teva Pharmaceutical Industries Ltd
- Boehringer Ingelheim International GmbH
- Cadila Healthcare Ltd.
- Cipla Ltd.
- Dr. Reddy's Laboratories Ltd.
- GlaxoSmithKline plc
- Hetero Labs Ltd.
- Jubilant Generics Ltd.
- Lupin Ltd.
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi S.A.
- Sun Pharmaceutical Industries Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | February 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 2.68 Billion |
| Forecasted Market Value ( USD | $ 3.38 Billion |
| Compound Annual Growth Rate | 6.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 30 |
